Lataa...
同种异基因CAR-T细胞治疗复发/难治多发性骨髓瘤四例临床观察并文献复习
OBJECTIVE: To investigate the safety and efficacy of allogeneic CAR-T cells in the treatment of relapsed/refractory multiple myeloma (RRMM). METHODS: CAR-T cells were prepared from peripheral blood lymphocytes of HLA mismatch healthy donors. Median age was 55 (48–60). Allogeneic cells were derived f...
Tallennettuna:
| Julkaisussa: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Editorial office of Chinese Journal of Hematology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342886/ https://ncbi.nlm.nih.gov/pubmed/31495131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.08.005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|